ImageneBio, Inc. (IMA)
4.165
+0.06
(+1.59%)
USD |
NASDAQ |
Nov 05, 16:00
ImageneBio Total Liabilities (Quarterly) : 9.971M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.971M |
| March 31, 2026 | 13.36M |
| December 31, 2025 | 19.84M |
| September 30, 2025 | 21.05M |
| June 30, 2025 | 10.26M |
| March 31, 2025 | 12.59M |
| December 31, 2024 | 17.45M |
| September 30, 2024 | 14.76M |
| June 30, 2024 | 14.63M |
| March 31, 2024 | 17.44M |
| December 31, 2023 | 22.34M |
| September 30, 2023 | 28.15M |
| June 30, 2023 | 15.06M |
| March 31, 2023 | 17.38M |
| Date | Value |
|---|---|
| December 31, 2022 | 25.29M |
| September 30, 2022 | 31.68M |
| June 30, 2022 | 36.82M |
| March 31, 2022 | 34.79M |
| December 31, 2021 | 40.00M |
| September 30, 2021 | 58.44M |
| June 30, 2021 | 62.57M |
| March 31, 2021 | 66.02M |
| December 31, 2020 | 269.45M |
| September 30, 2020 | 139.26M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 147.44M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 152.04M |
| Shareholders Equity (Quarterly) | 142.07M |
| Debt to Equity Ratio | 0.0315 |
| Current Ratio | 21.47 |
| Net Debt Paydown Yield | 0.64% |